CompletedNot Applicable

Interstitial Brachytherapy Boost for Treatment of Anal Canal Cancers, Comparison of Two Dose Rates

France89 participantsStarted 2007-08-17

Plain-language summary

Comparative retrospective study of two anal canal brachytherapy techniques aimed at boosting \[low dose rate (LDR) and high dose rate (HDR)\]

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients treated by brachytherapy anal canal to boost. Exclusion Criteria: * Patients below age of 18 years

Evaluation of the efficacy of interstitial brachytherapy of the anal canal

Timeframe: 1 year

Evaluation of the tolerance of interstitial brachytherapy of the anal canal

Timeframe: 1 year

NCT IDNCT03465501

SponsorInstitut Paoli-Calmettes

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2016-07-28